Nephrogenic diabetes insipidus tertiary prevention

Nephrogenic diabetes insipidus Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Nephrogenic diabetes insipidus from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Nephrogenic diabetes insipidus tertiary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nephrogenic diabetes insipidus tertiary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nephrogenic diabetes insipidus tertiary prevention
CDC on Nephrogenic diabetes insipidus tertiary prevention
Nephrogenic diabetes insipidus tertiary prevention in the news
Blogs on Nephrogenic diabetes insipidus tertiary prevention
Directions to Hospitals Treating Nephrogenic diabetes insipidus
Risk calculators and risk factors for Nephrogenic diabetes insipidus tertiary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Tertiary Prevention

Prevention or reduction of serious renal, ureteral, or bladder dilatation may be achieved by reduction of urine production by drug therapy and voiding at two-hour intervals.

Restriction of water intake.

References

Template:WikiDoc Sources